Epinephrine

Epinephrine — better known outside clinical settings as adrenaline — is a catecholamine molecule that serves as both a hormone and a neurotransmitter. Released from the adrenal glands in response to perceived threat or stress, it orchestrates the body's rapid-mobilisation state: more blood to the muscles, more fuel in the bloodstream, a faster and harder-beating heart.

It is synthesised in the adrenal medulla from its close relative norepinephrine (noradrenaline), and the two molecules share most of the same receptor targets and downstream effects. The distinction matters mostly in scale: norepinephrine is the everyday workhorse of sympathetic signalling; epinephrine is the surge that follows acute stress or danger.

How it works · its role

Epinephrine acts by binding to adrenergic receptors, which fall into two broad families — alpha and beta — each with subtypes distributed differently across tissues. Beta-1 receptors in the heart speed and strengthen the heartbeat. Beta-2 receptors in the lungs dilate the airways. Alpha receptors in the blood vessels tighten them, driving up blood pressure.

At the same time, epinephrine signals the liver to release stored glucose and suppresses non-urgent functions — digestion, immune activity, the urge to sleep. The overall effect is a rapid shift of resources toward immediate physical action, a state commonly called fight-or-flight.

After the surge, the enzyme COMT (COMT) and monoamine oxidase (MAO) break epinephrine down, returning the body toward baseline.

Relevance to substances & effects

Stimulant substances interact most directly with epinephrine pathways. Cocaine blocks the reuptake of catecholamines, allowing epinephrine and norepinephrine to remain active in the synapse longer than normal. Amphetamines force their release from nerve terminals, producing a sustained sympathetic surge — raised heart rate, elevated blood pressure, reduced appetite, heightened alertness.

MDMA also drives catecholamine release alongside its better-known serotonergic effects, contributing to the cardiovascular load of that substance. Even caffeine, through adenosine blockade and downstream signalling, nudges the adrenal system toward mildly elevated epinephrine output.

The subjective texture of epinephrine activation is the physical anxiety signature many users recognise: racing heart, tightening chest, sharpened focus, difficulty sitting still. High-dose stimulants, or stimulants combined with physical exertion, push this system harder, and the cardiovascular effects become the main risk factor.

Clinical · risk note

Because epinephrine raises heart rate and blood pressure, substances that amplify its activity carry cardiovascular risk that scales with dose, the user's baseline health, and concurrent stimulation. Combining multiple stimulant substances, or using stimulants during vigorous physical exertion or in hot environments, can push heart rate and core temperature into dangerous ranges.

People with pre-existing cardiac conditions, hypertension, or hyperthyroidism are more sensitive to this axis. Monoamine oxidase inhibitors (MAOIs) block the breakdown of catecholamines; combining an MAOI with a stimulant that forces epinephrine or norepinephrine release can produce a hypertensive crisis — a sharp, dangerous spike in blood pressure that warrants immediate medical attention.